Kenvue Inc. (FRA:J4D)

Market Cap	30.46B -20.2%
Revenue (ttm)	12.86B -2.1%
Net Income	1.25B +42.7%
EPS	0.65 +41.3%
Shares Out	n/a
PE Ratio	24.37
Forward PE	16.56
Dividend	0.71 (4.54%)
Ex-Dividend Date	Feb 11, 2026

Volume	500
Average Volume	46
Open	15.69
Previous Close	15.22
Day's Range	15.69 - 15.72
52-Week Range	11.83 - 22.62
Beta	n/a
RSI	57.66
Earnings Date	Feb 17, 2026

About Kenvue

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other...

• Industry: Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2022
• Employees: 22,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: J4D

Financial Performance

In 2025, Kenvue's revenue was $15.12 billion, a decrease of -2.14% compared to the previous year's $15.46 billion. Earnings were $1.47 billion, an increase of 42.72%.

Financial numbers in USD